BSC
VKTX icon

BOLTON SECURITIES CORPORATION’s Viking Therapeutics VKTX Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63.1K Hold
1,935
– – ﹤0.01% 1270
2026
Q2 		$75.5K Sell
1,935
-50
-3% -$1.62K ﹤0.01% 1187
2026
Q1 		$64.6K Buy
+1,985
New +$63.8K ﹤0.01% 1160
2025
Q3 		$368K Buy
+13,985
New +$417K 0.02% 591
2025
Q1 		$62.4K Buy
+2,585
New +$81.7K ﹤0.01% 988

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's VKTX Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION held its Viking Therapeutics (VKTX) position steady in Q3 2026 at 1,935 shares worth $63.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

BOLTON SECURITIES CORPORATION first reported a position in VKTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $368K in Q3 2025. 255 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 1,935 shares of Viking Therapeutics worth $63.1K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION left its Viking Therapeutics share count unchanged in Q3 2026.
  • Viking Therapeutics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1270 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Viking Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • BOLTON SECURITIES CORPORATION's Viking Therapeutics position peaked at $368K in Q3 2025.
  • 255 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.